AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.39 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -19.81%. A quarter ago, it was expected that this company would post earnings of $0.24 per share when it actually produced earnings of $0.22, delivering a surprise of -8.33%.Over the last four quarters, the compa ...

Industry Overview - The cannabis industry is expected to see significant changes by 2026, with potential for increased momentum in marijuana stocks due to U.S. federal reform aimed at improving profitability among leading operators [1] - Expanding international medical markets are also anticipated to play a crucial role for investors in the cannabis sector [1] Market Dynamics - Global partnerships between different cannabis markets are emerging as a key trend, suggesting selective but compelling investment opportunities for informed investors [2] - Staying updated on trends and company developments is essential for determining the performance of individual marijuana stocks [2] Investment Strategy - Despite the volatility in the cannabis sector, the potential rewards may justify the risks, with 2026 seen as a transitional year from speculative hype to fundamental value creation [3] - Investors who focus on regulatory awareness, financial analysis, and strategic diversification will be well-positioned to benefit from the next growth phase in marijuana stocks [3] Company Highlights - **Planet 13 Holdings Inc.** has exited the California cannabis market as of February 12, 2026, to concentrate on other growth markets, reflecting a strategic decision to streamline operations [7][8] - **Jushi Holdings Inc.** has opened a new Beyond Hello™ location in Ohio, marking its second retail outlet in Cincinnati, which is part of its strategic growth plan in the state [10][11]

Core Insights - Haemonetics reported quarterly earnings of $1.31 per share, exceeding the Zacks Consensus Estimate of $1.27 per share, and up from $1.19 per share a year ago [1] - The company achieved a revenue of $338.97 million for the quarter, surpassing the Zacks Consensus Estimate by 1.44%, although this represents a decline from $348.54 million in the same quarter last year [3] Earnings Performance - The earnings surprise for the recent quarter was +3.15%, following a previous surprise of +13.39% when earnings were $1.27 per share against an expectation of $1.12 per share [2] - Haemonetics has consistently surpassed consensus EPS estimates over the last four quarters [2] Stock Performance and Outlook - Haemonetics shares have declined approximately 17.7% since the beginning of the year, contrasting with a 0.5% gain in the S&P 500 [4] - The current consensus EPS estimate for the upcoming quarter is $1.30, with expected revenues of $334.48 million, and for the current fiscal year, the estimate is $4.93 on $1.32 billion in revenues [8] Industry Context - The Medical - Products industry, to which Haemonetics belongs, is currently ranked in the bottom 29% of over 250 Zacks industries, indicating potential challenges for stock performance [9] - Empirical research suggests that trends in earnings estimate revisions are strongly correlated with near-term stock movements, which may impact Haemonetics' future performance [6]

Industry Overview - The legal cannabis industry is experiencing significant changes, particularly with cannabis now classified as a Schedule 3 substance in the US, which facilitates further research and banking reform efforts [1][2] - Global investment in marijuana stocks is increasing, driven by the expansion of cannabis products in various markets and the potential for substantial profits in the sector [2][3] Company Highlights - **Greenlane Holdings, Inc. (NASDAQ:GNLN)**: Engages in the development and distribution of cannabis accessories and vape devices. Recently announced a partnership with Infrared Finance to deploy 30 million units of BERA into validator infrastructure [4][7][8] - **Jushi Holdings Inc. (OTC:JUSH)**: A vertically integrated cannabis company involved in cultivation, processing, retail, and distribution. Recently opened its second Beyond Hello location in Cincinnati, Ohio, expanding its retail footprint to 7 locations in the state and a total of 43 nationwide [9][10] - **Trulieve Cannabis Corp. (OTC:TCNNF)**: Operates as a cannabis retailer, cultivating and distributing cannabis products. Recently closed a US$60 million private placement of 10.5% senior secured notes, bringing the total issued notes to US$200 million [11]

Core Insights - Jushi Holdings Inc. has announced the grand opening of its Beyond Hello™ dispensary in Northern Cincinnati, marking the 7th location in Ohio and the 43rd nationwide [3][5]. Company Expansion - The new dispensary officially opened on January 8, 2026, with a grand opening celebration scheduled for January 23, 2026, featuring exclusive promotions [4][10]. - This location is strategically situated along the Springfield Pike corridor, providing easy access for residents and commuters in the greater Cincinnati area [7]. - Jushi continues to expand its vertically integrated operations in Ohio, cultivating and manufacturing a portfolio of in-house brands [11]. Product Offering - The dispensary will offer a wide selection of premium cannabis products, including flower, vapes, concentrates, edibles, and wellness options, supported by a knowledgeable team of cannabis professionals [8]. Market Strategy - Ohio is identified as a strategic growth market for Jushi, with the company emphasizing the importance of its presence in the Cincinnati area to provide a trusted retail experience [11].

Core Insights - Jushi Holdings Inc. has opened its 43rd retail location nationwide and the 7th Beyond Hello dispensary in Ohio, specifically in Northern Cincinnati [2][7][10] - The grand opening celebration is scheduled for January 23, 2026, featuring exclusive promotions for customers [9][10] Company Expansion - The new dispensary is strategically located along the Springfield Pike corridor, providing easy access for residents and commuters in the greater Cincinnati area [5] - Jushi continues to expand its vertically integrated operations in Ohio, cultivating and manufacturing a portfolio of in-house brands [10] Product Offering - The dispensary will offer a wide selection of premium cannabis products, including flower, vapes, concentrates, edibles, and wellness options [6] - Customers will receive support from a knowledgeable team of cannabis professionals dedicated to education and personalized service [6]

Core Insights - The legal cannabis market is a multi-billion-dollar industry that continues to grow, attracting investors looking for opportunities in 2026 [1] - Despite companies reporting record earnings, stock performance has not always reflected this success, indicating a disconnect between trading and actual company performance [2] - As 2026 begins, it is crucial for investors to stay informed and develop strategies to capitalize on changes in the cannabis industry [3] Company Highlights - **Trulieve Cannabis Corp.**: Operates as a cannabis retailer, cultivating, processing, and distributing cannabis products. Recently closed a $140 million private placement deal and supports the rescheduling of cannabis to a Class 3 substance, which could benefit legal operators like Trulieve [4][6] - **Planet 13 Holdings Inc.**: Engages in the cultivation and provision of cannabis products for medical and retail markets in the U.S. [7] - **Jushi Holdings Inc.**: A vertically integrated cannabis company involved in cultivation, processing, retail, and distribution for medical and adult-use markets. Recently amended its CEO's employment agreement, including a $1,050,000 annual cash bonus [9][11] Investment Opportunities - Investors are encouraged to watch specific marijuana stocks as the market evolves in 2026, with Trulieve, Planet 13, and Jushi Holdings being highlighted as key players [3][8]

Industry Overview - The cannabis industry is poised for significant growth in 2026, especially with the recent reclassification of cannabis from Schedule 1 to Class 3, which could facilitate import and export opportunities [2][3] - The changing legal landscape in the U.S. and other regions is expected to boost investor confidence and create a more robust market for cannabis operators globally [3] Company Highlights - **Green Thumb Industries Inc. (OTC:GTBIF)** reported Q3 2025 earnings with a revenue of $291.4 million, reflecting a 1.6% increase year-over-year. The company had cash on hand of $226.2 million and a GAAP net income of $23.3 million, translating to $0.10 per share. Adjusted EBITDA was $80.2 million, representing 27.5% of revenue [10] - **Jushi Holdings Inc. (OTC:JUSHF)** is a vertically integrated cannabis company involved in cultivation, processing, retail, and distribution for medical and adult-use markets. The company recently amended the CEO's employment agreement, which was approved by independent directors [11][12] - **Greenlane Holdings, Inc. (OTC:GNLN)** focuses on the development and distribution of cannabis accessories and vape devices. In its Q3 2025 update, the company reported total revenue of $0.74 million, with operating expenses of $4.0 million and a net loss of $8.9 million [12][13] Investment Opportunities - The article suggests that investors should keep an eye on several marijuana stocks for potential gains in 2026, including Green Thumb Industries, Jushi Holdings, and Greenlane Holdings [4][9]

Industry Overview - Donald Trump's executive order to move cannabis from Schedule I to Schedule III marks a significant change for the U.S. cannabis sector, altering its federal legal status and implications for operators, investors, and public markets [1] - The rescheduling is expected to eliminate IRS Section 280E, which currently restricts cannabis businesses from deducting standard operating expenses, leading to improved financial conditions for the industry [2] Financial Implications - The removal of Section 280E could enhance profit margins and cash flow for cannabis companies, strengthening their balance sheets and enabling reinvestment and consolidation [2] - Companies with strong fundamentals are likely to benefit the most as financial metrics normalize, attracting institutional capital and expanding analyst coverage over time [3] Investment Opportunities - Investors are advised to focus on operators with positive cash flow potential post-280E rather than engaging in broad speculation [3] - Several marijuana stocks are highlighted for potential investment, including Green Thumb Industries Inc., Ayr Wellness Inc., and Jushi Holdings Inc. [8] Company Highlights - **Green Thumb Industries Inc.** reported Q3 2025 revenue of $291.4 million, a 1.6% increase year-over-year, with a GAAP net income of $23.3 million and adjusted EBITDA of $80.2 million, representing 27.5% of revenue [9] - **Ayr Wellness Inc.** is undergoing restructuring under the Companies' Creditors Arrangement Act, transitioning core assets to a new acquisition vehicle owned by senior noteholders [10][12] - **Jushi Holdings Inc.** is a vertically integrated cannabis company involved in cultivation, processing, and retail, with recent amendments to the CEO's employment agreement approved by independent directors [14]

BOCA RATON, Fla., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announces that in order to assist the Company in managing near-term working capital requirements, the Company and Jim Cacioppo, the Company’s Chairman and Chief Executive Officer, have agreed to certain amendments to Mr. Cacioppo’s employment agreement (collectively, the “Employment Agreement Amendments”). All of the Employment ...